Literature DB >> 24853271

Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant.

E Mimiola1, O Marini, O Perbellini, A Micheletti, W Vermi, S Lonardi, C Costantini, E Meneghelli, A Andreini, C Bonetto, A Vassanelli, M Cantini, E Zoratti, D Massi, A Zamo', A Leso, G Quaresmini, F Benedetti, G Pizzolo, M A Cassatella, C Tecchio.   

Abstract

The role of dendritic cells (DCs) and macrophages in allogeneic haematopoietic stem cell transplant (HSCT) is critical in determining the extent of graft-versus-host response. The goal of this study was to analyse slanDCs, a subset of human proinflammatory DCs, in haematopoietic stem cell (HSC) sources, as well as to evaluate their 1-year kinetics of reconstitution, origin and functional capacities in peripheral blood (PB) and bone marrow (BM) of patients who have undergone HSCT, and their presence in graft-versus-host disease (GVHD) tissue specimens. slanDCs were also compared to myeloid (m)DCs, plasmacytoid (p)DCs and monocytes in HSC sources and in patients' PB and BM throughout reconstitution. slanDCs accounted for all HSC sources. In patients' PB and BM, slanDCs were identified from day +21, showing median frequencies comparable to healthy donors, donor origin and kinetics of recovery similar to mDCs, pDCs, and monocytes. Under cyclosporin treatment, slanDCs displayed a normal pattern of maturation, and maintained an efficient chemotactic activity and capacity of releasing tumour necrosis factor (TNF)-α upon lipopolysaccharide (LPS) stimulation. None the less, they were almost undetectable in GVHD tissue specimens, being present only in intestinal acute GVHD samples. slanDCs reconstitute early, being donor-derived and functionally competent. The absence of slanDCs from most of the GVHD-targeted tissue specimens seems to rule out the direct participation of these cells in the majority of the local reactions characterizing GVHD.
© 2014 British Society for Immunology.

Entities:  

Keywords:  dendritic cells; haematopoietic stem cell transplant; immune reconstitution

Mesh:

Substances:

Year:  2014        PMID: 24853271      PMCID: PMC4360203          DOI: 10.1111/cei.12387

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation.

Authors:  Konrad Mager; Rebekka Wehner; Felix Bahr; Uta Oelschlägel; Uwe Platzbecker; Martin Wermke; Nona Shayegi; Jan Moritz Middeke; Jörgen Radke; Christoph Röllig; Johannes Schetelig; Christian Thiede; Gerhard Ehninger; Marc Schmitz; Martin Bornhäuser; Sebastian Tuve
Journal:  Transplantation       Date:  2012-06-27       Impact factor: 4.939

2.  Proinflammatory human 6-sulfo LacNAc-positive dendritic cells accumulate in intestinal acute graft-versus-host disease.

Authors:  Ulrich Sommer; Brit Larsson; Sebastian Tuve; Rebekka Wehner; Nick Zimmermann; Michael Kramer; Anja Kloβ; Claudia Günther; Jana Babatz; Renate Schmelz; Stefan Brückner; Johannes Schetelig; Martin Bornhäuser; Knut Schäkel; Michael Philipp Bachmann; Daniela Aust; Gustavo Baretton; Marc Schmitz
Journal:  Haematologica       Date:  2014-03-28       Impact factor: 9.941

3.  slanDCs selectively accumulate in carcinoma-draining lymph nodes and marginate metastatic cells.

Authors:  William Vermi; Alessandra Micheletti; Silvia Lonardi; Claudio Costantini; Federica Calzetti; Riccardo Nascimbeni; Mattia Bugatti; Manuela Codazzi; Patrick C Pinter; Knut Schäkel; Nicola Tamassia; Marco A Cassatella
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

4.  Early evaluation of immune reconstitution following allogeneic CD3/CD19-depleted grafts from alternative donors in childhood acute leukemia.

Authors:  A Pérez-Martínez; M González-Vicent; J Valentín; E Aleo; A Lassaletta; J Sevilla; J L Vicario; M Ramírez; M A Díaz
Journal:  Bone Marrow Transplant       Date:  2012-03-12       Impact factor: 5.483

5.  The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells.

Authors:  A M Woltman; J W de Fijter; S W Kamerling; L C Paul; M R Daha; C van Kooten
Journal:  Eur J Immunol       Date:  2000-07       Impact factor: 5.532

Review 6.  Immune reconstitution after hematopoietic cell transplantation.

Authors:  Mark Bosch; Faisal M Khan; Jan Storek
Journal:  Curr Opin Hematol       Date:  2012-07       Impact factor: 3.284

7.  Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution.

Authors:  Phennapha Klangsinsirikul; G Ian Carter; Jennifer L Byrne; Geoff Hale; Nigel H Russell
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

8.  Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients.

Authors:  Susanne Auffermann-Gretzinger; Izidore S Lossos; Tamara A Vayntrub; Wendy Leong; F Carl Grumet; Karl G Blume; Keith E Stockerl-Goldstein; Ronald Levy; Judith A Shizuru
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

9.  FcγRIII (CD16) equips immature 6-sulfo LacNAc-expressing dendritic cells (slanDCs) with a unique capacity to handle IgG-complexed antigens.

Authors:  Thomas Döbel; Anja Kunze; Jana Babatz; Katja Tränkner; Andreas Ludwig; Marc Schmitz; Alexander Enk; Knut Schäkel
Journal:  Blood       Date:  2013-03-04       Impact factor: 22.113

10.  Characterization of human afferent lymph dendritic cells from seroma fluids.

Authors:  Barbara Morandi; Irene Bonaccorsi; Mario Mesiti; Romana Conte; Paolo Carrega; Gregorio Costa; Raffaella Iemmo; Stefania Martini; Soldano Ferrone; Claudia Cantoni; Maria Cristina Mingari; Lorenzo Moretta; Guido Ferlazzo
Journal:  J Immunol       Date:  2013-09-27       Impact factor: 5.422

View more
  2 in total

Review 1.  Current Concepts on 6-sulfo LacNAc Expressing Monocytes (slanMo).

Authors:  Fareed Ahmad; Thomas Döbel; Marc Schmitz; Knut Schäkel
Journal:  Front Immunol       Date:  2019-05-22       Impact factor: 7.561

Review 2.  6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes.

Authors:  Thomas P Hofer; Arjan A van de Loosdrecht; Christiane Stahl-Hennig; Marco A Cassatella; Loems Ziegler-Heitbrock
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.